Meagan Montesion

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers

Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins et al. · JCI Insight · 2019 · 538 citations · Full text

Medicine, Cancer Biology, Oncology +17

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion et al. · Journal for ImmunoTherapy of Cancer · 2021 · 292 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Discovery of unfixed endogenous retrovirus insertions in diverse human populations

Julia H Wildschutte, Zachary H. Williams, Meagan Montesion et al. · Proceedings of the National Academy of Sciences · 2016 · 289 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal

James Sun, Yuting He, Eric M. Sanford et al. · PLoS Computational Biology · 2018 · 286 citations · Full text

Medicine, Genetics, Oncology +17

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin et al. · Cancer Discovery · 2020 · 248 citations · Full text

Medicine, Immunology, Oncology +17